Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Beta Bionics, Inc. (“Beta Bionics” ...

Beta Bionics now carries an updated fair value estimate of US$23.80 per share, up from about US$21.67, which refines how ...

Beta Bionics, Inc. BBNX recently announced a partnership with Senseonics SENS to expand compatibility between its automated insulin delivery (AID) platform and Senseonics’ continuous glucose ...

Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its third quarter 2026 financial results ...

IRVINE, Calif., November 13, 2024 (Newswire.com) - Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announces the successful closing of a $60 ...

Beta Bionics (BBNX), a maker of insulin delivery devices, has filed for a $100M initial public offering. Beta Bionics (BBNX) hopes to list its shares on Nasdaq under the symbol BBNX. Lead bookrunners ...

Wandercraft said it has acquired Ekso Bionics, another developer of medical exoskeletons for patients. The companies did not ...